Ecological Momentary Intervention for Reward in Anhedonia
Launched by PHILIPPS UNIVERSITY MARBURG ·
Trial Information
Current as of September 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new two-week program designed to help people who have anhedonia—a condition where someone finds it hard to feel pleasure—as well as anxiety, stress, or depression. The program uses daily exercises delivered through a smartphone app that encourage positive thinking, gratitude, and enjoying good moments. These activities aim to help people better anticipate and enjoy rewards, which can improve mood and reduce psychological distress. Another group in the study practices muscle relaxation exercises, so researchers can compare the effects of the two approaches.
People aged 65 to 74 who are experiencing symptoms like anhedonia, anxiety, stress, or depression may be eligible to join. Participants will be asked to complete three short exercises each day using audio recordings on their phone. This study is currently recruiting volunteers, and it offers a simple way to try new strategies that might improve emotional well-being over just two weeks.
Gender
ALL
Eligibility criteria
About Philipps University Marburg
Philipps University Marburg, established in 1527, is one of Germany's oldest universities and a leading institution in research and education. Known for its commitment to advancing medical science, the university actively sponsors clinical trials aimed at enhancing healthcare outcomes. With a focus on innovative therapies and interdisciplinary collaboration, Philipps University Marburg leverages its expertise in various medical fields to contribute to cutting-edge research and the development of new treatment modalities. Its robust infrastructure and dedication to ethical research practices ensure the integrity and efficacy of its clinical studies, making it a pivotal player in the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported